Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A 0.05% Eye Drops in Ocular Cicatricial Pemphigoid
2008-000480-41Phase 3Active
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jun 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cyclosporine in ocular cicatricial pemphigoid (OCP) and chronic conjunctivitis (2 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Relapse frequency. Started Jun 2008; status: active.
02
Drugs
cyclosporine
03
Conditions
ocular cicatricial pemphigoid (OCP)chronic conjunctivitis
Beyond the preview
Go deeper on 2008-000480-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000480-41.